Research and development of a new generation of biosensors to accelerate the discovery of multi target Alzheimer's disease therapeutics modulating amyloid aggregation and other biomolecular targets such as acetylcholinesterase. Analysis on biosensors to detect biomolecular targets in response to therapeutics using miniaturized, cost-effective and rapid techniques.
- Biomedical Young Investigator Award, Alzheimer Society of Canada (2010)
- Ontario Early Researcher Award (2012)
- CNC-IUPAC Travel Award (2014)
- X. R. Cheng, A. J. Veloso, K. Kerman, Reflection spectroscopy for the determination of Au nanostructure formation on carbon surfaces, Talanta, 2011, in press.
- V. W. S. Hung, K. Kerman, Gold electrodeposition on carbon nanotubes for the enhanced electrochemical detection of homocysteine,Electrochem. Commun., 2011, 13, 328-330.
- V. Dounin, A. Constantinof, H. Schulze, T. T. Bachmann, K. Kerman, Electrochemical detection of interaction between Thioflavin T and acetylcholinesterase, Analyst, 2011, 136, 1234-1238.
- D. Fiorella, X. R. Cheng, T. Chan, K. Kerman, Electrochemical detection of AChE-induced gold nanostructure growth on disposable chips, Electrochem. Commun., 2011, 13, 190-193.
- T. Chan, A. M. Chow, D. Tang, I. R. Brown, Q. Li, S. Wang, K. Kerman,Interaction of baicalein and copper with alpha-synuclein: Electrochemical approach to the Parkinson's Disease,J. Electroanal. Chem.,2010,648, 151-155.
For more publications see: http://www.utsc.utoronto.ca/~kkerman/index.htm